2001
DOI: 10.1038/sj.onc.1203840
|View full text |Cite
|
Sign up to set email alerts
|

Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
62
1
2

Year Published

2001
2001
2016
2016

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 71 publications
(67 citation statements)
references
References 58 publications
2
62
1
2
Order By: Relevance
“…(61,62) Cellular senescence and crisis are the host defense mechanisms to suppress tumorigenesis. Knowledge of cellular senescence has accumulated during the last decade demonstrating the profound difference between mouse and human systems in several aspects, (63)(64)(65)(66) especially the critical contribution of telomere checkpoint control in cellular senescence of human cells. Overcoming processes of active oncogeneinduced senescence (OIS) is critical for cancer formation, not only in vitro but also in vivo.…”
Section: −10mentioning
confidence: 99%
“…(61,62) Cellular senescence and crisis are the host defense mechanisms to suppress tumorigenesis. Knowledge of cellular senescence has accumulated during the last decade demonstrating the profound difference between mouse and human systems in several aspects, (63)(64)(65)(66) especially the critical contribution of telomere checkpoint control in cellular senescence of human cells. Overcoming processes of active oncogeneinduced senescence (OIS) is critical for cancer formation, not only in vitro but also in vivo.…”
Section: −10mentioning
confidence: 99%
“…HBV is a DNA tumor virus, which encodes four open reading frames, S/preS, C/preC, P, and HBx (4). The oncogenicity of HBV is largely the result of HBx, the smallest gene encoding a 17-kDa protein (3,(5)(6)(7)(8). One major cellular function of HBx is its promiscuous transcriptional activation activity, a property that is believed to contribute to its oncogenicity (9).…”
Section: Hepatocellular Carcinoma (Hcc)mentioning
confidence: 99%
“…These changes could occur in a variety of cellular genes leading to escape from normal cellular and environmental controls. So far, over 20 cellular genes down-or up-regulated or mutated in HCC such as ras (Ogata et al, 1991;Kim et al, 2001), c-myc, c-fos, and c-jun (Kawate et al, 1999;Yuen, et al, 2001), rho (Genda et al, 1999), TGFa (Chung et al, 2000), HGF and c-met (Ueki et al, 1997), c-erbB-2 (Collier et al, 1992), IGF-II (Takeda et al, 1996), u-PA (de Petro et al, 1998), MXR7 (Hsu et al, 1997), MDM2 (Endo et al, 2000), MAGE (Tahara et al, 1999), matrix metalloproteinase (Musso et al, 1997), Smads (Yakicier et al, 1999), p53 (Shimizu et al, 1999;Rashid et al, 1999), pRB Santoni-Rugiu et al, 1998), p16INK4 Liew et al, 1999), p21 WAF1/CIP1 , p27 Kip1 (Chen et al, 2000;Tannapfel et al, 2000), PTEN (Fujiwara et al, 2000;Yao et al, 1999), E-cadherin ), beta-catenin (de La Coste et al, 1998 and AXIN1 (Satoh et al, 2000) have been described in humans and mice. Many of them are involved in deregulation of intracellular signal transduction and cell cycle, leading eventually to an uncontrolled proliferation of cancerous cells.…”
Section: Introductionmentioning
confidence: 99%